Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has ...

Dr Reddy’s Laboratories ( ($RDY) ) has provided an update. Dr. Reddy’s Laboratories announced on November 24, 2025, that it has received European ...

Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has granted marketing authorizations for Teva's biosimilars PONLIMSI and DEGEVMA e ...

The latest update is out from Alvotech ( (ALVO) ).

Dr Reddy's Laboratories has received European Commission authorisation for AVT03, a biosimilar of Prolia and Xgeva, used to treat osteoporosis.

The company's arm received approval from GIDC on Nov. 24, 2025, for the transfer of rights in leasehold land measuring about ...

Anti-vaccine sentiment is alive and well, especially in the U.S. And it was evident in recent weeks as drugmakers revealed ...

Asian markets, which tracked the overnight US market’s rally, also traded positively. Japan’s Nikkei 225 was up by 0.52%, ...

Akston, the Biotech Built for Pets, announced today the start of a clinical study at Cornell University College of Veterinary Medicine to evaluate its once-weekly GLP-1 weight-management therapy for ...

On the sectoral front, metal, pharma, PSU Bank and realty added 0.5-1%, while consumer durables, IT, media, oil & gas shed ...

Dr. Reddy's Laboratories has secured European Commission marketing approval for AVT03, a biosimilar to Prolia and Xgeva, used ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...